Magnetic Resonance Imaging Guided Robotic Catheter System for Left Atrial Appendage Occlusion Procedures
Magnetic Resonance Imaging Guided Robotic Catheter System for Left Atrial Appendage Occlusion Procedures
批准号:
10666474
负责人:
Hiram Bezerra
金额:
$84.61万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2026-06-30
关键词:
3-DimensionalAgeAlgorithmsAnatomyAnimalsAnticoagulationAreaArrhythmiaAtrial FibrillationBlood coagulationCardiacCardiologyCathetersCessation of lifeChronicClinicalClinical ResearchDataData CollectionDetectionDevelopmentDevicesExposure toFluoroscopyGoalsHemorrhageHospitalizationHumanHuman ResourcesImageImplantImplantation procedureInterventionIntracranial HemorrhagesIonizing radiationLeftLife ExpectancyLocationMagnetic Resonance ImagingMechanicsMedical ImagingMethodsOperative Surgical ProceduresOralPatientsPerformancePharmaceutical PreparationsPhysiciansPositioning AttributePrevalencePrevention therapyProbabilityProceduresPuncture procedureResearchResearch PersonnelResolutionRiskRisk FactorsRisk ReductionRoboticsSafetyScheduleSchemeSpeedStrokeStroke preventionStudy SubjectSystemTechnologyThrombusTimeTransesophageal EchocardiographyTransfusionUltrasonographyUnited StatesUser-Computer InterfaceValidationVertebratesVisualizationWorkanatomic imagingauricular appendagecardiac magnetic resonance imagingcomparative efficacycostcost effectivedesign and constructionefficacy studyexperienceexperimental studyflexibilityheart imaginghuman subjectimage guidedimprovedin vivomagnetic fieldminimally invasivenew technologynovelnovel strategiespatient populationpre-clinicalpreventprototypereconstructionresearch studyrobot controlscreeningsealsoft tissuestroke risksuccesstechnology developmenttherapy developmentthree-dimensional visualization
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Atrial fibrillation is the most common form of cardiac arrhythmia, with prevalence estimated to be 5.2 million in
2010 and predicted to increase to 12.1 million in 2030. Atrial fibrillation is a major risk factor for blood clots and
stroke, independently increasing stroke risk 4- to 5-fold throughout all ages. Therefore, the vast majority of
patients with atrial fibrillation require some form of stroke prevention therapy. Current first line stroke prevention
therapy for atrial fibrillation patients is life-long use of oral anti-coagulation medications, which are associated
with increase in bleeding risk by approximately 2- to 2.5-fold, including intracranial hemorrhage, that may lead
to hospitalization, transfusion, surgery, and death.
The purpose of the present study is to improve stroke prevention treatment for non-valvular atrial fibrillation by
transforming the Left Atrial Appendage Occlusion (LAAO) procedure into a first line therapy for a larger segment
of patient populations, especially for younger patients with 20+ year of life expectancy who are likely to
experience bleeding problems in their lifetimes. LAAO is a minimally invasive procedure where an implant
delivered using an intravascular catheter is used to permanently seal off the left atrial appendage mechanically
to reduce the risk of blood clots. The barriers preventing LAAO from becoming a first line therapy are primarily
safety and cost. The investigators aim to overcome these barriers and transform LAAO into a first line therapy
by developing a real-time Magnetic Resonance Imaging (MRI)-guided robotic intravascular catheter system for
performing LAAO procedures by synergistically combining novel medical imaging, robotic catheter control, and
advanced visualization technologies to improve the safety, cost, and workflow of LAAO procedures.
The proposed technology expands on novel approaches initiated by the investigators in earlier work in the areas
of real-time MRI image acquisition and reconstruction, robotic catheters actuated using the magnetic field of the
MRI scanner, advanced visualization, and volumetric planning of LAAO. The project is organized into three
Specific Aims, each focusing on one key aspect of the procedure workflow, namely, procedure planning,
transseptal puncture, and LAAO implant delivery. These Specific Aims build on crosscutting technical research
on MRI, robotics, and human-machine interface technologies, where the investigators will develop novel
technologies for rapid and flexible 2D/3D cardiac MRI imaging, robotically controlled MRI-compatible dexterous
cardiac catheters, and human-machine interfaces with advanced visualization.
The end result of this proposal will be the complete prototype of an MRI-guided robotic catheter system for
performing LAAO procedures combining real-time intraoperative MRI, robotic catheter control, and advanced
visualization technologies to facilitate safer, more efficient, and cost-effective LAAO procedures. The developed
system and the underlying technologies will be validated by experts in interventional cardiology in vertebrate
animal and non-clinical human studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computer assisted coronary artery stent interventions
-
批准号:9589254
-
项目类别:
-
资助金额:$74.35万
-
财政年份:2018
-
负责人:Hiram Bezerra
-
依托单位:
Computer assisted coronary artery stent interventions
-
批准号:10201734
-
项目类别:
-
资助金额:$68.9万
-
财政年份:2018
-
负责人:Hiram Bezerra
-
依托单位:
In vivo Characterization of Stents using Intravascular OCT Imaging
-
批准号:8529140
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2013
-
负责人:Hiram Bezerra
-
依托单位:
In vivo Characterization of Stents using Intravascular OCT Imaging
-
批准号:9097737
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2013
-
负责人:Hiram Bezerra
-
依托单位:
In vivo Characterization of Stents using Intravascular OCT Imaging
-
批准号:8724992
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2013
-
负责人:Hiram Bezerra
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: